Research

162 articles

Equity Research

Company-level stock analysis, valuation, margins, balance sheet risk, and rating rationale.

Sep 25, 2026Cameco Stock Analysis: Buy or Sell? Valuation, FCF & Leverage
Sep 24, 2026Charter Communications Stock Analysis: Buy or Sell? Leverage & FCF
Sep 23, 2026EPR Properties Stock Analysis: Buy or Sell? Leverage, FCF & Tenant Risk
Sep 23, 2026Brookfield Asset Management Stock Analysis: Buy or Sell? Valuation & Fee Growth

View all Equity Research →

84 articles

The Scorecard

Post-publication reviews that check what happened after earlier Buy and Sell calls.

Sep 26, 20261 Month Update: ALT Sell — Correct so far
Sep 25, 20262 Month Update: NLST Sell — Incorrect so far
Sep 25, 20261 Month Update: LHX Sell — Correct so far
Sep 24, 20262 Month Update: QUBT Sell — Incorrect so far

View all The Scorecard →

82 articles

SEC What Changed

Daily filing-change notes comparing new 10-K language with prior-year disclosures.

View all SEC What Changed →

6 articles

Weekly Performance

Friday performance updates for the public LF0 research track record.

Sep 25, 2026Weekly Performance, Sep 25, 2026: 64.3%, 0.71%
Sep 18, 2026Weekly Performance, Sep 18, 2026: +3.9%, +68.6%
Sep 11, 2026Weekly Performance, Sep 11, 2026: 67.3%, 4.7%
Sep 7, 2026Weekly Performance, Sep 7, 2026: 57.4%, 2.79%

View all Weekly Performance →

The Scorecard
SMR
The Scorecard: SMR Strong Sell — Correct so far
Sep 11, 2026
Revisiting our Strong Sell call on SMR: entry $8.81, latest $8.61, -2.3%.
Read note
The Scorecard
VSAT
The Scorecard: 2 Month Update: VSAT Sell — Incorrect so far
Sep 11, 2026
Revisiting our Sell call on VSAT: entry $69.54, latest $74.18, +6.7%.
Read note
The Scorecard
ADTN
The Scorecard: 1 Month Update: ADTN Sell — Correct so far
Sep 11, 2026
Revisiting our Sell call on ADTN: entry $7.76, latest $7.18, -7.5%.
Read note
SEC What Changed
ECXJ, FLWS, GWRE, HWKE, LPTH, RSSS, SMBC
Hawkeye Digital (HWKE) 10-K: Risk Factors Changes Lead 11 September 2026 Filing Roundup
Sep 11, 2026
Hawkeye Digital (HWKE)’s Risk Factors section changed the most among 7 companies that filed 10-Ks on 11 September 2026, each compared against its prior-year…
Read note
Weekly Performance Update
BMNR, BW, FLNC, MTZ, NLST, SMR
Weekly Performance Update — September 11, 2026
Sep 11, 2026
Across 139 tracked articles, our hit rate is 67.3% and our average signal return is 4.7%, so the book is still working overall. This run, Sell is the strongest tier on a meaningful sample, while Strong Sell is the weakest, though that tier only has 2
Read note
SEC What Changed
AENT, AUSI, CBKM, EGAN, GOLD, IBEX, MCFT, PANW, PLUR
Palo Alto Networks (PANW) 10-K: MD&A Changes Lead 10 September 2026 Filing Roundup
Sep 10, 2026
Palo Alto Networks (PANW)’s MD&A section changed the most among 9 companies that filed 10-Ks on 10 September 2026, each compared against its prior-year filing.
Read note
The Scorecard
WGS
The Scorecard: 1 Month Update: WGS Sell — Incorrect so far
Sep 9, 2026
Revisiting our Sell call on WGS: entry $77.88, latest $85.87, +10.3%.
Read note
The Scorecard
SKYH
The Scorecard: 3 Month Update: SKYH Sell — Incorrect so far
Sep 9, 2026
Revisiting our Sell call on SKYH: entry $9.37, latest $10.36, +10.6%.
Read note
SEC What Changed
GCBC, INM, INNV, INTU, LSAK
InMed Pharmaceuticals (INM) 10-K: Business Changes Lead 9 September 2026 Filing Roundup
Sep 9, 2026
InMed Pharmaceuticals (INM)’s Business section changed the most among 5 companies that filed 10-Ks on 9 September 2026, each compared against its prior-year…
Read note
SEC What Changed
EVI
EVI Industries (EVI) 2026 10-K Analysis: Risk Factors Changes
Sep 8, 2026
EVI Industries (EVI) 2026 10-K analysis comparing the 8 September 2026 filing with its prior-year 10-K, highlighting the Risk Factors section’s biggest changes.
Read note

Get future lf0 research notes by email.

Equity research, scorecards, weekly performance updates, and SEC filing-change summaries.

Subscribe to lf0 Research Notes